The Indiana Clinical and Translational Sciences Institute (CTSI) announced that University of Notre Dame researchers have been awarded grants through the CTSI Pilot Funding program. The program is intended to promote the use of technologies and expertise available through CTSI Core Facilities, which are available at the partner institutions.
The Indiana Clinical and Translational Sciences Institute (CTSI) is a statewide collaboration of Indiana University, Purdue University, and the University of Notre Dame, as well as public and private partnerships. Established in 2008, the Indiana CTSI is supported by a $25 million Clinical and Translational Science Award from the National Center for Advancing Translational Sciences (NCATS) of the National Institutions of Health, supplemented by nearly $60 million from the state, the three member universities, and public and private partnerships. The Indiana CTSI is a member of a national network of 61 CTSA-funded organizations across the United States. In 2013, the Indiana CTSI received a competitive renewal providing an additional $30M to continue its efforts for the next five years.
NCATS Clinical and Translational Science Awards (CTSA) program is designed to strengthen and support the entire spectrum of translational research from scientific discovery to improved patient care.
Accelerate Translational Research • Enhance Access to State-of-the-Art Technologies • Promote Education and Training • Connect State and Regional Researchers and Capabilities • Foster Community Engagement
Each year, SPARK, a Stanford University initiative that provides the education and mentorship in order to advance research discoveries from the bench to the bedside, hosts a diverse group to participate in a 12-day training course in biotech innovation and entrepreneurship. The program provides an understanding of how biotechnology products, such as medical devices, food science, and general medical science, and companies are created, established, managed, advertised, and funded. Ricardo Romero, graduate student of the Integrated Biomedical Sciences program and researcher in the Harper Cancer Research Institute, had the opportunity to attend the program through the Indiana Clinical and Translational Sciences Institute (Indiana CTSI).